Suchergebnisse - "Dolci, Giovanni"

PubPharm (7)

1

Tocilizumab or glucocorticoids treatment for patients with SARS-CoV-2 pneumonia : An observational study

enthalten in: The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases | 2022

von Dolci, G. | Cassone, G. | Besutti, G. | +8

2

Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab : A monocentric retrospective analysis

enthalten in: PloS one | 2022

von Cassone, G. | Dolci, G. | Besutti, G. | +15

3

The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study

enthalten in: PloS one | 2021

von Milic, J. | Banchelli, F. | Meschiari, M. | +30

4

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia : A Randomized Clinical Trial

enthalten in: JAMA internal medicine | 2021

von Salvarani, C. | Dolci, G. | Massari, M. | +36

CommentIn: JAMA Intern Med. 2021 Jan 1;181(1):12-15. - PMID 33079980

5

TOCIVID-19 - A multicenter study on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia. Study protocol

enthalten in: Contemporary clinical trials | 2020

von Piccirillo, M. | Ascierto, P. | Atripaldi, L. | +18

6

Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia

enthalten in: Clinical and experimental rheumatology | 2020

von Cassone, G. | Dolci, G. | Besutti, G. | +23

7

Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

enthalten in: Journal of translational medicine | 2020

von Perrone, F. | Piccirillo, M. | Ascierto, P. | +134

ErratumIn: J Transl Med. 2021 Oct 21;19(1):442. - PMID 34674735

1
[1]